-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hangzhou, September 29, 2021/PRNewswire/ - China's leading one-stop biopharmaceutical CDMO platform Hangzhou Haoyang Biotechnology Co.
Antibody-conjugated drugs (ADCs) are composed of monoclonal antibodies (mAb), linkers (linker), and cytotoxin/payload.
This year, domestic companies have made dynamic progress in ADC.
Based on the current good domestic ADC R&D market atmosphere, Hunda Biotech and Haoyang Biotech jointly provide customers with ADC product pre-process development, intermediate scale amplification and GMP production services according to the agreement
Mr.
Mr.
About Hunda Bio
Zhejiang Hui of Biotechnology Limited (Zhejiang Huida Biotech Co.
About Haoyang Bio
Founded in November 2015, Haoyang Biotechnology is a national high-tech enterprise engaged in the development of therapeutic antibodies and recombinant protein drugs
Source: Hangzhou Haoyang Biotechnology Co.